Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CFTR | P13569 | 5/20 | 0.42 |
| ▸ | MAPT | P10636 | 3/20 | 0.41 |
| ▸ | NOTUM | Q6P988 | 4/20 | 0.41 |
| ▸ | SOS1 | Q07889 | 1/20 | 0.40 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 3/20 | 0.38 |
| ▸ | KDR | P35968 | 1/20 | 0.36 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9720001 | 0.84 | HTT (0.46) | MAPTKDM4EHTTGAALMNA | |
| SCHEMBL23727828 | 0.80 | NOTUM (0.51) | CFTRMAPTNOTUMSOS1KDM4E | |
| SCHEMBL23745445 | 0.79 | CFTR (0.43) | CFTRMAPTNOTUMSOS1KDM4E | |
| SCHEMBL23727491 | 0.78 | CFTR (0.47) | CFTRMAPTNOTUMSOS1KDM4E | |
| SCHEMBL22203102 | 0.78 | CFTR (0.47) | CFTRMAPTNOTUMSOS1KDM4E | |
| SCHEMBL23040878 | 0.77 | CFTR (0.68) | CFTRMAPTNOTUMSOS1KDM4E | |
| SCHEMBL23727489 | 0.75 | CFTR (0.44) | CFTRMAPTNOTUMSOS1HTT | |
| SCHEMBL27447768 | 0.75 | CFTR (0.47) | CFTRMAPTNOTUMSOS1GAA | |
| SCHEMBL30039399 | 0.74 | CFTR (0.43) | CFTRMAPTNOTUMSOS1KDM4E | |
| SCHEMBL27699890 | 0.74 | CFTR (0.56) | CFTRNOTUMSOS1KDM4ELMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115052596-B | ADAMTS inhibitor, preparation method and medical application thereof | 江苏恒瑞医药股份有限公司 | 2024-06-14 | — | — | CN | disclosed |
| CN-117136051-A | Prodrugs of ADAMTS inhibitors, preparation method and medical application thereof | 江苏恒瑞医药股份有限公司 | 2023-11-28 | — | — | CN | disclosed |
| WO-2023011547-A1 | CRYSTAL FORM OF COMPOUND INHIBITING FUNCTION OF ADAMTS-5 AND/OR ADAMTS-4, AND PREPARATION METHOD THEREFOR AND USE THEREOF | 江苏恒瑞医药股份有限公司 | 2023-02-09 | — | — | WO | disclosed |
| EP-4100005-A1 | ADAMTS INHIBITORS, PREPARATION METHODS AND MEDICINAL USES THEREOF | Jiangsu Hengrui Pharmaceuticals Co., Ltd. (CN) | 2022-12-14 | — | — | EP | disclosed |
| WO-2022212638-A1 | PRODRUGS OF ADAMTS INHIBITORS, PREPARATION METHODS AND MEDICINAL USES THEREOF | JIANGSU HENGRUI PHARMACEUTICALS CO., LTD. (CN) | 2022-10-06 | — | — | WO | disclosed |
| CN-115052596-A | ADAMTS inhibitor, preparation method and medical application thereof | 江苏恒瑞医药股份有限公司 | 2022-09-13 | — | — | CN | disclosed |
| WO-2021158626-A1 | ADAMTS INHIBITORS, PREPARATION METHODS AND MEDICINAL USES THEREOF | Eternity Bioscience Inc. (US) | 2021-08-12 | — | — | WO | disclosed |
| WO-2021158626-A1 | ADAMTS INHIBITORS, PREPARATION METHODS AND MEDICINAL USES THEREOF | Eternity Bioscience Inc. (US) | 2021-08-12 | — | — | WO | disclosed |